Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Pinnacle Oncology LLC Acquires Rights to Unique Radioprotector From the University of Chicago

June 27, 2011 By Bio-Medicine.Org

BANNOCKBURN, Ill., June 27, 2011 /PRNewswire/ — Pinnacle
Oncology LLC, a subsidiary of Pinnacle Biologics Inc. announced a
wide ranging agreement with the University of Chicago for the
acquisition of its technology and intellectual property rights for
the development of a compound, amifostine, to prevent genomic
instability caused by a variety of sources of ionizing radiation
exposure including common Computer Tomography (CT) scans.

Amifostine was initially developed by the United States Army to
protect military personnel from the toxic effects of radiation
exposure in the event of a nuclear war.  Animal studies
revealed that amifostine is very effective in protecting against
genomic instability and associated long term genomic damages
resulting from radiation exposure, such as from CT scans and other
diagnostic radiology and radiation oncology procedures that lead to
DNA damages, chromosomal aberrations and gene mutations, all of
which are associated with the cancer development processes.

“There are many potential uses for amifostine,” said David
Grdina, Professor of Radiation and Cellular Oncology at the
University of Chicago and inventor of the technology behind the
development of amifostine as a genomic stabilizing agent, “In
addition to protecting against genomic instability, somatic
mutagenesis and carcinogenesis, amifostine may also facilitate
protection against germ line mutations. These exposures can come
from a variety of sources including common diagnostic procedures,
such as computer tomography (CT) scans and more generalized
environmental exposures, as recently evidenced by the nuclear plant
accident in Japan.”  At present, none of these potential uses
have been approved by the FDA.

According to Viren Grover, Vice-Chairman at Pinnacle Biologics,
“It is clear that CT scans have revolutionized diagnostic imaging
and while they can provide great medical benefits, there is concern
that diagnostic CT scans may be responsi

‘/>”/>

SOURCE

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Biotronik
FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech